Tofacitinib shows promise in PsA trials | Nature Reviews Rheumatology
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
Figure 3 from The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. | Semantic Scholar
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology | Immunology
Pharmacology and safety of tofacitinib in ulcerative colitis | Gastroenterología y Hepatología (English Edition)
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance | Frontline Gastroenterology
Tofacitinib in ulcerative colitis | Immunotherapy
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on th | JIR
Current and future status of JAK inhibitors - The Lancet
References in JAK inhibitors in 2019, synthetic review in 10 points - European Journal of Internal Medicine
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
Tofacitinib has a unique multitiered mechanism of action with an early... | Download Scientific Diagram
Tofacitinib restores the balance of γδTreg/γδT17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists | Pharmacology
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Tofacitinib and Other Kinase Inhibitors in the Treatment of Psoriasis | Actas Dermo-Sifiliográficas
Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis - Clinical Trials Arena
Tofacitinib has a unique multitiered mechanism of action with an early... | Download Scientific Diagram
